Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Si

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
Journal of Cancer Research and Clinical Oncology|July 20, 2023
A nomogram incorporating Ki67 to predict survival of acral melanomaYu Du, Caili Li, Lili Mao, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2020
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanomaLu Si, Xiaoshi Zhang, Sang Joon Shin, et al.
The Oncologist|August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatmentLi Zhou, Min Cao, Haibin Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2017
Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitorJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Journal of Cancer|April 1, 2020
A Functional Synonymous Variant in <i>PDGFRA</i> Is Associated with Better Survival in Acral MelanomaJie Dai, Lu Yang, Tianxiao Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-IIIYang Wang, Bin Lian, Lu Si, et al.
Ebiomedicine|April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinomaXinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
Journal of Cancer Research and Clinical Oncology|July 20, 2023
A nomogram incorporating Ki67 to predict survival of acral melanomaYu Du, Caili Li, Lili Mao, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2020
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanomaLu Si, Xiaoshi Zhang, Sang Joon Shin, et al.
The Oncologist|August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatmentLi Zhou, Min Cao, Haibin Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2017
Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitorJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.
Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.
Journal of Cancer|April 1, 2020
A Functional Synonymous Variant in <i>PDGFRA</i> Is Associated with Better Survival in Acral MelanomaJie Dai, Lu Yang, Tianxiao Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-IIIYang Wang, Bin Lian, Lu Si, et al.
Ebiomedicine|April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinomaXinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Pageof 23